SCHEMBL9531799

SCHEMBL9531799

CC(C)Cc1cn(-c2ccccc2)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.41

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 5/20 0.41
AGTR2 P50052 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9534205 0.91 AGTR1 (0.44) AGTR1AGTR2
SCHEMBL9554318 0.90 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9536402 0.88 AGTR1 (0.49) AGTR1AGTR2
SCHEMBL9535572 0.88 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9529754 0.87 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL6491639 0.86 AGTR1 (0.56) AGTR1AGTR2
SCHEMBL9529697 0.86 AGTR1 (0.40) AGTR1AGTR2
SCHEMBL9553892 0.86 AGTR1 (0.47) AGTR1AGTR2
SCHEMBL9553675 0.86 AGTR1 (0.45) AGTR1AGTR2
SCHEMBL9531691 0.85 AGTR1 (0.40) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5238952-A Treating glaucoma disorders G. D. SEARLE & CO. (US) 1993-08-24 US disclosed
EP-0555331-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS. SEARLE & CO (US) 1993-08-18 EP disclosed
EP-0544705-A1 DERIVATIVES OF MUPIROCIN Beecham Group p.l.c. (GB) 1993-06-09 EP disclosed
WO-1992007834-A1 N-SUBSTITUTED IMIDAZOL-2-ONE COMPOUNDS FOR TREATMENT OF CIRCULATORY DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed
WO-1992002518-A1 DERIVATIVES OF MUPIROCIN BEECHAM GROUP PLC (GB) 1992-02-20 WO disclosed
US-5087634-A N-substituted imidazol-2-one compounds for treatment of circulatory disorders G. D. SEARLE & CO. (US) 1992-02-11 US disclosed